← Leaderboards
Nicholas Khoo
University Of Pittsburgh At Pittsburgh
$680,523
Attributed
$1,361,046
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350.5K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,361,046 · 1
By mechanism
R01$1,361,046 · 1
Top collaborators
- Eric Eugene Kelley4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Eric Eugene Kelley$2,318,020
- Alicia R Mathers$4,373,803
- Hulya Bayir$16,376,338
- Yuan Liu$4,548,206
- Sruti Shiva$9,895,872
Others in their field
Other Emerging Leaders on “Acids”
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,259,745
- Bala Raja · Luminostics, Inc.$28,624,460
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,132,807
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Dave Beebe · Flambeau Diagnostics Llc$16,670,000
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
AcidsAdult ObesityAnalogAnti-Inflammatory AgentsBenignCardiovascular DiseasesCatabolismCholesterolChronic Kidney FailureChronic Liver DiseaseCirrhosisComplexDietDyslipidemiasEnzymesEpidemicFast FoodFatty Acid Glycerol EstersFatty LiverFda ApprovedFebuxostatFeedingFibrosisFructose
Grant awards (4)
Targeting Uric Acid as a Therapeutic for NASH$336,143
R01 · FY2023 · DK · contact PI
Targeting Uric Acid as a Therapeutic for NASH$336,854
R01 · FY2022 · DK · contact PI
Targeting Uric Acid as a Therapeutic for NASH$337,544
R01 · FY2021 · DK · contact PI
Targeting Uric Acid as a Therapeutic for NASH$350,505
R01 · FY2020 · DK · contact PI